Health is our business
3 Oct/ 0 Comment
Specialized meeting of the nephrology department of Shahid Labbafinejad Hospital
In line with the programs set to introduce the new formulation of tacrolimus drug with the brand Advagraf in the form of face-to-face and online programs in the transplant market of Iran, on Wednesday, 03/06/1400, a seminar entitled:
“Challenges in Renal Transplantation in Covid Era”
For 1 hour from 13:00 to 14:00 in the form of meetings of the nephrology group of Labbafinejad Hospital, sponsored by Astellas Company and attended by the target group of this program, professors and students of all adult courses were held.
In this seminar, which was led by Dr. Shiva Samavat, Professor of Nephrology, Shahid Beheshti University of Medical Sciences, Dr. Sara Keshtakari, Nephrology Fellowship, Labbafinejad Hospital, gave a very comprehensive lecture on the initial introduction, mechanism of action and pharmacodynamics of Advagraf and the difference In two areas of Adherence and Intra-patient variability with Immediate Release Tacrolimus based on "agreement and consensus of the risk management factor of changeable factors in transplantation":
“Consensus on Managing Modifiable Risk in Transplantation”
Which was very well received.
We hope to take an effective step towards sharing the experiences of professors and improving the condition of transplant patients by holding coherent scientific programs.